Izotropic Corporation

Commercializing a Dedicated Breast CT Platform for the Earlier Detection, Diagnosis and Treatment of Breast Cancers

Recent News

  • Izotropic stellt kommerziellen IzoView-Prototyp vor und reicht neue Patente ein

    Vancouver, British Columbia--(Newsfile Corp. - Donnerstag, 12. Mai 2022) - Die Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Unternehmen, das seine Brust-CT (Computertomographie)-Bildgebungsplattform IzoView für die genauere Brustkrebserkennung und -diagnose kommerzialisiert, freut sich, das kommerzielle Prototyp-Gerätedesign vorzustellen, das in bevorstehenden klinischen Studien zur Marktzulassung in den USA eingesetzt wird.

    2022-05-12 4:53 PM EDT
  • Izotropic Unveils Izoview Commercial Prototype, Files New Patents

    Vancouver, British Columbia--(Newsfile Corp. - May 10, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, is pleased to unveil the commercial prototype device design that will be used in forthcoming clinical studies for market authorization in the U.S.

    2022-05-10 8:00 AM EDT
  • Izotropic Corporation Announces Closing of Non-Brokered Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - April 4, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, is pleased to announce, further to its news release on March 30, 2022, that it has completed a non-brokered private placement (the "Offering") of unsecured promissory notes (each, a "Note") pursuant to which the Company issued: (i) Notes purchased for an aggregate...

    2022-04-04 8:00 AM EDT
  • Autorität für Brust-CT und Leiterin klinischer Studien tritt Izotropic bei

    Vancouver, British Columbia--(Newsfile Corp. - Dienstag, 15. März 2022) - Die Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Unternehmen, das eine spezielle Brust-CT-Bildgebungsplattform IzoView (Computertomographie) für die genauere Brustkrebserkennung und -diagnose vermarktet, freut sich, die Ernennung von Dr. Shadi Aminololama-Shakeri, MD, FSBI, in seinen Beirat und sein Kommerzialisierungsteam als klinische Beraterin bekanntzugeben. Dr. Shakeri ist Leiterin der Abteilung für Brustradiologie am University of California Davis Medical Center (

    2022-03-15 6:49 PM EDT
  • Breast CT Authority and Head of Clinical Trials Joins Izotropic

    Vancouver, British Columbia--(Newsfile Corp. - March 14, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, is pleased to announce the addition of Dr. Shadi Aminololama- Shakeri, MD, FSBI to its advisory board and commercialization team as a clinical consultant. Dr. Shakeri is the Chief of the Division of Breast Radiology at...

    2022-03-14 8:00 AM EDT
  • Izotropic baut eine Technologie- und Entwicklungsanlage in den USA auf

    Vancouver, British Columbia--(Newsfile Corp. - Dienstag, 8. März 2022) - Die Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Unternehmen, das eine spezielle Brust-CT (Computertomographie) Bildgebungsplattform, IzoView, für die genauere Erkennung und Diagnose von Brustkrebs vermarktet, gibt bekannt, dass es seine medizinische Gerätetechnik und Produktentwicklung in seine interne Einrichtung in Sacramento, CA, verlegen wird.Der Schritt kommt zu einem kritischen Zeitpunkt, da Izotropic Geräte für seine zukünftigen klinischen Studien zur Marktzulassung in den USA und anderswo fertigt. Während das Unternehmen...

    2022-03-08 12:51 PM EST
  • Izotropic Establishing Engineering and Development Facility in the USA

    Vancouver, British Columbia--(Newsfile Corp. - March 7, 2022) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers announces it is bringing its medical device engineering and product development to its in-house facility located in Sacramento, CA.The move comes at a critical time as Izotropic is building devices for its future clinical studies for market...

    2022-03-07 8:00 AM EST
  • Izotropic Implements Quality Management System For IzoView Breast CT Device Manufacturing

    Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers is pleased to announce that it has implemented a Quality Management System (QMS) for regulatory and manufacturing purposes.The QMS is a system of procedures and processes covering aspects of a product lifecycle from the design, manufacturing, supplier management, risk management, clinical...

    2021-11-29 2:00 AM EST